Corbus Pharmaceuticals Holdings, Inc. (CRBP) Total liabilities 2016–2022
Corbus Pharmaceuticals Holdings, Inc. (CRBP) total liabilities at each fiscal year-end, per SEC filings.
$33.3MFY2022 · since FY2016: $9.0M → $33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $33.3M | -13.7% |
| FY2021 | $38.6M | -32.3% |
| FY2020 | $57.0M | +32.7% |
| FY2019 | $43.0M | +120.8% |
| FY2018 | $19.5M | +111.7% |
| FY2017 | $9.2M | +2.5% |
| FY2016 | $9.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice